Eres PJ, Garcia-Mendez A, Lopez Farre A, Macaya C, Nunez A, Gomez J, Alonso-Orgaz S, Carrasco C, Burgos ME, de Andres R, Granizo JJ, Farre J, Rico LA: Proteomic analysis of plasma from patients during an acute coronary syndrome. J Am Coll Cardiol 2004, 44:1578-1583. 7. Koomen JM, Wilson CR, Guthrie P, Androlewicz MJ, Kobayashi R, Taegtmeyer H: Proteome analysis of isolated perfused organ effluent as a novel model for protein biomarker discovery. J Proteome Res 2006, 5:177-182. 8. Vollmer M, van de Goor T: HPLC-Chip/MS technology in proteomic profiling. Methods Mol Biol 2009, 544:3-15. 9. Li Y, Zhang Y, Qiu F, Qiu Z: Proteomic identification of exosomal LRG1: A potential urinary biomarker for detecting NSCLC. Electrophoresis 2011, 32:1976-1983. 10. Zhang Y, Li Y, Qiu F, Qiu Z: Comparative analysis of the human urinary proteome by 1D SDS-PAGE and chip-HPLC-MS/MS identification of the AACT putative urinary biomarker. J Chromatogr B Analyt Technol Biomed Life Sci 2010, 878:3395-3401. 11. IPI human database. [http://www.ebi.ac.uk/IPI].Abbreviations IHD: Ischemic heart disease; CK-MB: Creatine kinase muscle/brain isoform; CKM: Creatine kinase M-type; CKB: Creatine kinase B-type; cTnT: Cardiac troponin T; cTnI: Cardiac troponin I; ACS: Acute coronary syndromes; pI: Isoelectric point; MW: Molecular weight; MWCO: Molecular weight cutoff; DTT: Dithiothreitol; IMA: Iodoacetamide; HPLC: High performance liquid chromatography; MDH1: Malate dehydrogenase; MS: Mass spectrometry; IPI: International protein index; SPI: Scored peak intensity; EASE: Expression analysis systematic explorer; LDH: Lactate dehydrogenase; LDHB: Lactate dehydrogenase B; ASA: Aspartate aminotransferase; MB: Myohemoglobin;Li et al. Proteome Science 2012, 10:21 http://www.proteomesci.com/content/10/1/Page 11 of12. Agilent Technologies: Quantitative and qualitative information. [https:// www.chem.agilent.com/en-US/Products/software/chromatography/ms/ spectrummillformasshunterworkstation/Pages/gp7776.aspx]. 13. Lin D, Zuo Z: Isoflurane induces hippocampal cell injury and cognitive impairments in adult rats. Neuropharmacology 2011, 61:1354-1359. 14. Hosack DA, Dennis G Jr, Sherman BT, Lane HC, Lempicki RA: Identifying biological themes within lists of genes with EASE. Genome Biol 2003, 4: R70. 15. KEGGSOAP software. [http://www.bioconductor.org/packages/2.4/bioc/ html/KEGGSOAP.html]. 16. Hooper SD, Bork P: Medusa: a simple tool for interaction graph analysis. Bioinformatics 2005, Nelfinavir (Mesylate) 21:4432-4433. 17. Hardouin J, Duchateau M, Joubert-Caron R, Caron M: Usefulness of an integrated microfluidic device (HPLC-Chip-MS) to enhance confidence in protein PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/6833145 identifycation by proteomics. Rapid Commun Mass Spectrom 2006, 20:3236-3244. 18. Addona TA, Shi X, Keshishian H, Mani DR, Burgess M, Gillette MA, Clauser KR, Shen D, Lewis GD, Farrell LA, et al: A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease. Nat Biotechnol 2011, 29:635-643. 19. Park SM, Hwang IK, Kim SY, Lee SJ, Park KS, Lee ST: Characterization of plasma gelsolin as a substrate for matrix metalloproteinases. Proteomics 2006, 6:1192-1199. 20. Bucki R, Levental I, Kulakowska A, Janmey PA: Plasma gelsolin: function, prognostic value, and potential therapeutic use. Curr Protein Pept Sci 2008, 9:541-551. 21. Ali MA, Cho WJ, Hudson B, Kassiri Z, Granzier H, Schulz R: Titin is a target of matrix metalloproteinase-2: implications in myocardial ischemia/ reperfu.